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HAEMATOLOGICAL ABNORMALITIES IN 
CIRRHOSIS OF LIVER 
 
INTRODUCTION 
 
Cirrhosis is one of the commonest diseases affecting man. Hepatic cirrhosis can occur 
at any age and often causes prolonged morbidity. It frequently manifests itself in 
younger adults and is an important cause of premature death. 
 
Liver disease produces a diverse range of haemotological effects. Liver disease can 
affect all the formed elements of blood RBCS, WBCS, and platelets. Liver disease has 
important effects on haemostasis. 
 
The liver plays a central role in the synthesis of many proteins and the maintenance of 
metabolic homeostasis. It is therefore not surprising that the development of clinically 
important liver diseases is accompanied by diverse manifestations. Although some 
functions are more sensitive than others, the liver has considerable reserve capacity, 
so, minimal or even moderate cell injury may not be reflected by measurable 
functional changes. 
 
Impaired liver functions are most evident in the patient with advanced liver disease, 
and the manifestations are similar regardless of initial insult. To a varying degree, 
similar abnormalities are observed in patients with severe chronic hepatitis, 
micronodular cirrhosis and post necrotic cirrhosis. 
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CIRRHOSIS OF THE LIVER. 
Cirrhosis is obtained from the Greek word” KIRRHOS” meaning tawny or yellowish 
brown. It was coined by Laennec. 
Cirrhosis is pathologically defined entity that is associate with a spectrum of clinical 
manifestations. The cardinal pathological features are, 
I. Fibrosis is present in the form of delicate bands (portal-central, portal- portal, central 
– central) or broad scars replacing multiple adjacent lobule. 
II. The parenchymal architecture of the entire liver is disrupted by inter connecting 
fibrous scars. 
III. Parenchymal nodules are created by generation of hepatocytes. 
Several features should be underscored. 
 
1. The changes in cirrhosis affect the whole liver but not necessarily every 
lobule, Focal injury with scarring does not constitute cirrhosis. The 
parenchymal injury and consequent fibrosis are diffuse extending throughout 
the liver. Focal injury with scarring does not constitute cirrhosis. 
 
2. Nodularity is requisite for the diagnosis and reflects the balance between 
regenerative activity and constrictive scarring. 
 
3. The fibrosis once developed is generally irreversible. 
 
4. Destruction of the liver architecture causes distortion and loss of the normal 
hepatic vasculature with the development of portal systemic vascular shunts. 
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CLASSIFICATION BASED ON ETIOLOGY. 
1. Alcoholism. 
2. Post infective- chronic viral infection: HIV, HBV+HDV, HCV. 
3. Drugs and toxins. 
4. Auto immune chronic liver diseases. 
5. Metabolic disorders. 
a) Haemochromatosis. 
b) Wilson’s disease. 
c) Alpha1 anti-trypsin deficiency. 
d) Cystic fibrosis. 
e) Glycogen storage diseases. 
f) Galactosemia. 
g) Hereditary Fructose Intolerance. 
h) Hereditary Tyrosinemia. 
i) Ornithine transcarbamylase deficiency. 
j) Abeta lipoproteinaemia. 
k) Porphyria. 
6. Biliary tract disease( prolonged) 
a) Extra hepatic biliary obstruction. 
b) Intra hepatic biliary obstruction. 
c) Primary biliary cirrhosis. 
d) Primary sclerosing cholangitis. 
7. Venous outflow obstruction. 
a) Veno occlusive disease. 
b) Budd chiari syndrome. 
c) Cardiac failure. 
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8. Others. 
a) Obesity. 
b) Diabetes Mellitus. 
c) Intestinal bypass. 
d) Sarcoidosis 
e) Syphilis. 
f) Indian Childhood cirrhosis. 
CLINICAL FEATURES OF CIRRHOSIS. 
Cirrhotic patients commonly present with the following symptoms. They are, 
1. Anorexia and nausea. 
2. Haemetemesis / malena. 
3. Fatigue and weight loss. 
4. Abdominal distension / pedal edema. 
5. Jaundice. 
6. Low grade fever 
7. loss of libido 
Clinical manifestations in cirrhosis are due to  
1. Portal Hypertension 
2. Prolonged alcohol intake 
3. Diminished Hepato cellular function. 
The following stigmata of chronic liver disease should be looked for. 
FACE: 
1. Parotid enlargement. 
2. Madarosis. 
3. Telangiectasia 
4. Xanthelasma 
5. Cushingoid Facies. 
6. Pallor. 
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HANDS: 
1. Anaemia 
2. Whitenails. 
3. Dupuytren’s contracture. 
4. Palmar erythema 
5. Clubbing. 
NUTRITION: 
1. Muscle wasting 
2. Glossitis 
3. Angular stomatitis. 
4. Anaemia 
SKIN: 
1. Spider Naevi 
2. Scanty body hair. 
3. Slate gray pigmentation. 
4. Scratch marks. 
ENDOCRINE ABNORMALITIES: 
1. Gynaecomastia. 
2. Testicular atrophy. 
FEATURES DUE TO PORTAL HYPERTENSION: 
1. Splenomegaly. 
2. Ascites. 
3. Oesophageal varices. 
4. Anorectal varices. 
5. Dilated veins over the abdomen ( Caput Medusae) 
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COMPENSATED vs. DECOMPENSATED CIRRHOSIS. 
COMPENSATED CIRRHOSIS. 
The disease may be discovered at a routine examination or biochemical screen or at 
operation undertaken for some other condition. Cirrhosis may be suspected if the 
patient has mild pyrexia, vascular spiders, palmar erythema or unexplained epistaxis or 
edema of ankles. Firm enlargement of the liver and splenomegaly are helpful 
diagnostic signs. Vague morning indigestion and flatulent dyspepsia may be early 
features in the alcoholic cirrhotic. Confirmation should be sought by biochemical tests 
and if necessary by liver biopsy. Biochemical test may be quite normal in this group. 
The most frequent changes are a slight increase in the serum GGT level. 
 
DECOMPENSATED CIRRHOSIS. 
The patient usually seeks medical advice because of ascites or jaundice. General health 
fails with weakness, muscle wasting and weigh loss.  Continuous mild fever is often 
due to gram negative bacteremia, to continuing hepatic cell necrosis or to complicating 
liver cell CA. Foetor hepaticus may be present. It is the commonest cause of hepatic 
encephalopathy. Jaundice implies that liver cell destruction exceeds the capacity for 
regeneration and is always serious. The deeper the jaundice, the greater the inadequacy 
of liver cell function. The liver may be enlarge with firm regular edge or contracted 
and impalpable. The spleen may be palpable. 
 
ROLE OF LIVER IN HAEMOPOIESIS. 
The liver has an important role as a haemopoietic organ in foetal life. It is the primary 
site of erythropoiesis in the foetus from the ninth to twenty fourth week of gestation. 
Thereafter bone marrow becomes the major source of RBC. Extra medullary 
haemopoiesis is found in the adult liver in certain pathological states. Eg. 
HEAMATOLOGICAL ABNORMALITIES IN CIRRHOSIS OF LIVER 
 
 
7
Myelofibrosis. Granulocytes precursors and megakaryocytes are also present I foetal 
liver but production does not become significant until haematopoiesis becomes 
established in the marrow. 
 
In adult the kidney is the main source of erythropoietin and liver is the site of 
clearance, however the liver can produce this hormone in the presence of uraemia, in 
response to hypoxia or hemolysis or when hepatocytes are regenerating. 
 
 The liver also plays an important role in the metabolism of iron, vitamin B12 and 
folate. Thus although the liver disease in adults rarely causes haemotological 
complications solely on the basis of defective haemopoiesis. The liver may, none the 
less have an importance role in facilitating bone marrow function. The precise 
mechanisms are not understood but disturbances of them may explain the suboptimal 
marrow response to Anaemia and thrombocytopenia seen in patients with liver disease. 
 
SYNTHESIS OF COAGULATION PROTEINS 
The liver is the main site of production of all the coagulation proteins except von 
willibrand Factor. The important synthetic role of liver is supported experimentally by 
showing a fall in factors I, II, VII, IX, X, XI, XII following chemically induced hepatic 
necrosis. 
 
Factor VIII is the synthesized by the hepatocyte and also in many other tissues and 
also is largely spared in liver diseases. Vitamin K dependant coagulation proteins are 
synthesized in the liver in a precursor form. They are II, VII, XI, and X. 
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NORMAL COAGULATION AND THE ROLE OF THE LIVER. 
Under normal conditions, blood circulates through the vasculature without appreciable 
coagulation or heamorrhage. When vessel injury occurs, three haemostatic responses 
are initiated. 
1. The vessel constricts 
2. Platelets adhere at the site of damage and subsequently aggregate and 
3. Fibrin clot is formed and modified 
 
The haemostatic response occurs in a stepwise, integrated manner. In primary 
haemostasis, vessels constrict and a temporary platelet plug is formed. Secondarily the 
platelet plug is reinforced with a durable fibrin clot. The fibrin clot is modified an after 
tissue healing ultimately dissolve by fibrinolytic components. The failure of any part 
of the haemostatic response may contribute to haemorrhage. The coexistence of 
multiple defects in the haemostatic system may have an additive effect, resulting in a 
profound haemorrhagic catastrophe. 
 
Vasoconstriction is an immediate but probable minor response to vascular injury. 
Small arteries and veins contract so as to decrease blood flow to the area. If 
haemorrhage occurs in a closed compartment such as joint space local pressure causes 
collapse of small vessels, thereby contributing to local control. In the absence of local 
tissue tension, as in gastro intestinal bleeding or haemorrhage from a large vessel, 
bleeding is more difficult to control. 
 
Platelets serve two functions. First they form a primary haemostatic plug. Second, they 
serve as a template for the generation of fibrin by way of the coagulation cascade. 
Platelet plug formation occurs in two phases. Platelet adhesion, which occurs within 
seconds, followed by platelet aggregation, which is complete within minutes. Platelet 
adhesion to the injured vessel requires the secretion of von willibrand Factor by 
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endothelial cells and the availability of platelet membrane glycoprotein Ib as a receptor 
for von willibrand Factor. Once adhesion occurs, platelets undergo a shape change 
with a coincident release of various mediators, including ADP, which stimulates 
platelets to aggregate and form the primary platelet plug. The aggregated platelets then 
provide the surface on which the fibrin plug is formed. In addition platelets serve as a 
source of phospholipids, in the form of platelet factor 3 required for the conversion of 
prothrombin to thrombin by factor X a. 
 
The exposed subendothelial components activate the coagulation cascade, either 
through contact activation of the intrinsic pathway or through expression of tissue 
factor at the site of injury with consequent extrinsic pathway activation. It is now 
recognized that the intrinsic and extrinsic pathway are not entirely independent of each 
other. Invitro and invivo studies support the observation that factor VII – tissue factor 
also activates factor IX. Through a complex sequence of reactions, clotting factor 
precursors are converted to their active form with the eventual generation of thrombin. 
Thrombin then transforms fibrinogen to fibrin is cross linked by factor XIIIa to form a 
stable fibrin clot. 
 
When fibrin is formed, plasminogen is bound to the clot. Tissue plasminogen activator 
is released from endothelial cells and then binds to the fibrin clot. On the fibrin 
surface, plasminogen is cleared, plasmin is generated and fibrin degradation ensues. 
Remodeling and eventual dissolution of the clot permit subsequent wound healing 
with the formation of fibrous tissue. In abnormal states, such as disseminated 
intravascular coagulation, plasmin may also be present in blood, and degrade 
fibrinogen and factors V, VIII, XIII. 
 
Modulation of coagulation and fibrinolysis occurs at various sites as listed in table (1). 
Control of coagulation is achieved by several measures. The liver inactivates activated 
factors further; natural inhibitors to various factors are present in plasma. 
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Antithrombin III (ATIII) is a major inhibitor of thrombin as well as factor XIIa, XIa, 
Xa and IXa. AT III also inhibits plasma kallikrein and plasmin. The activity of AT III 
is increased thousand fold in the presence of heparin, heparin or contact with 
endothelial cells, which are coated with heparin sulphate. 
 
Protein C is a second major inhibitor. This vitamin K dependant glycoprotein is 
synthesized in the liver and inactivates factors Va, VIIIa. In addition, protein C 
enhances fibrinolysis by inactivating plasminogen activator inhibitor type 1. Protein C 
is activated when thrombin is bound to the endothelial cell membrane protein 
thrombomodulin. 
 
Both anticoagulant and profibrinolytic activities of protein C are accelerated in the 
presence of the cofactor protein S, another vitamin K dependant protein. Activated 
protein C is inactivated by Alpha 1 antitrypsin and protein C inhibitor. 
 
Heparin cofactor H, a glycoprotein synthesized by liver, inactivates thrombin in the 
presence of heparin or dermatan sulphate. Extrinsic pathway inhibitor (also called 
lipoprotein associate coagulation inhibitor) inhibits coagulation, initiated by VIIa 
tissue factor complex by binding to factor Xa. The site of synthesis of extrinsic 
pathway inhibitor is still not certain. The major inhibitor of plasmin is alpha2 
antiplasmin which is synthesized in liver. Alpha2 macroglobulin, a second line 
inhibitor of plasmin and thrombin is synthesized by macrophages and possibly 
hepatocytes. TPA is inhibited by plasminogen activator inhibitor I, which is secreted 
by endothelial cells but also found in platelets. 
 
The liver plays a central role in haemostasis. In addition to its synthetic function the 
liver serves as a key site for clearance of activated clotting factors and plasminogen 
activators. 
 
HEAMATOLOGICAL ABNORMALITIES IN CIRRHOSIS OF LIVER 
 
 
11
OVERVIEW OF COAGULATION CASCADE 
INTRINSIC        EXTRINSIC 
Kallikrein     Prekallikrein                                                            VII 
                                       HMWK 
   XII                        XII a                                                            VIIa  +  TF 
                                       HMWK                                                  
           XI                                  XIa 
                            
   IX                        IXa 
                                                                Ca 
                                                 VIIIa              PL 
     X 
     V                                                                                                                           common 
 
                                                                                                                       XIII 
Prothrombin                                        Thrombin 
                                                                                                                       XIII a 
                                                                                                                                   Ca++ 
Fibrinogen                          fibrin Polymer                            Cross linked Fibrin 
 
                 FPA      Fibrin             
                 FPB       Monomer 
 
Xa     +        PL  
 
 
 
Va    +      Ca++
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FIBRINOLYTIC PATHWAY 
Fragments    Fragments               Fragments: XYE 
XYDE               XYDE                                Cross linked Fragments: 
                                                                                          D dimmer, HMW 
 
 
 
 
 
 
 
Fibrinogen   Fibrin Polymer  Cross linked Fibrin 
      | 
      | 
      | 
      | 
      |_  _  _  _  _  _  _  _  _ 
Plasminogen   Activator 
 
                                          Plasminogen 
 
 
Plasmin 
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AIM OF THE STUDY 
1. To detect various Haematological Abnormalities in Cirrhosis. 
 
2.  To Detect Reversible Factors like Anaemia, thrombocytopenia. So that 
correction of them may make the patients life less miserable. 
 
3. To assess haemostatic functions of the liver in cirrhosis. 
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REVIEW   OF   LITERATURE. 
 This discussion will highlight the intriguing newer concepts more in detail than the 
established ones. 
 
ALTERATION IN THE HAEMATOLOGICAL FUNCTIONS IN 
CIRRHOSIS. 
Liver disease may result in abnormalities of haemopoiesis ranging from morphological 
changes to varying degree of anaemia. White cell abnormalities also occur varying 
from Leucopenia to leucocytosis. Disturbed haemostasis is common and results from 
thrombocytopenia and impaired synthesis of coagulation factors. 
 
ANAEMIA IN LIVER DISEASES. 
Anaemia occurs in upto seventy five percent of patients with chronic liver disease. It is 
characteristically of moderate severity and is either normochromic normocytic or 
moderately macrocytic. The anaemia of liver disease results from  
1. Heamodilution 
2. Shortened RBC survival. 
3. Reduction of the capacity of marrow to respond to anaemia. 
4. Splenomegaly and hypersplenism resulting in pooling of RBCs & excessive 
destruction of RBCs. 
5. Haemorrhage. 
6. Haemolysis. 
The anaemia in liver disease usually varies from 7gm/dl to 13gm/dl.  Severe anaemia 
below 6gm/dl is very rare. 
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IRON METABOLISM IN CIRRHOSIS. 
A low or normal iron conc. with low or normal total iron binding capacity is frequently 
found in uncomplicated cirrhosis and is compatible with the anaemia of chronic 
disorder which is commonly seen in inflammatory and neoplastic disorders.  Iron 
deficiency is frequently found as a result of previous GI haemorrhage and the resulting 
anaemia often responds to oral iron therapy. 
 
An important practical point is that hepatic inflammation and necrosis tends to 
increase serum ferritin. So that a raised value does not necessarily indicate iron over 
load, and a normal value does not exclude iron deficiency.  The rise in RBC Mean 
Corpuscular volume which accompanies liver disease and alcoholic ingestion can also 
mask iron deficiency which is normally characterized by the lowering of Mean 
Corpuscular Volume. 
 
Iron in plasma is bound to a beta globulin transferring and total iron binding capacity 
largely depends on transferring conc. measurement of total iron binding capacity gives 
rough estimation regarding the iron deficiency. 
 
VITAMIN B12 AND FOLIC ACID METABOLISM. 
The liver is important storage organ for both vitamin B12 and folic acid.  Liver disease 
leads to several clinically significant disorders of their metabolism.  Lack of either 
vitamins leads to megaloblastic haemotopoiesis.  Alcohol can inhibit Vitamin B12 
absorption. Chronic alcoholism and dietary deficiency are the major cause of folate 
abnormalities reported in alcoholic cirrhosis are either due to direct toxicity of alcohol 
or to the associated nutritional deficiency.  Excessive intake of alcohol will have a 
direct toxic effect on blood and bone marrow and will result in metabolic 
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abnormalities and consequent haematopoietic abnormalities, RBCs, WBCs and platelet 
production may all be affected. 
 
Most of the cirrhotic patients are undernourished for years together, under-nutrition 
itself will contribute to further cirrhosis. The dietary intake is below par even with 
proper medical advice and treatment. Loss of appetite, fullness of the abdomen, pain 
abdomen may limit the intake of food in these patients. Indigestion and vomiting may 
also contribute to some extent.  Ultimately daily intake of protein and carbohydrates 
are much reduced than what is needed. 
 
 Protein in adequate amount is required for the erythropoiesis. Deficiency of this 
protein causes impaired erythropoiesis, leading on to anaemia. Deficiency of other 
vitamins like pyridoxine, Vit-C is likely to cause anaemia in these patients. More than 
75 % of 65 cases with chronic alcoholic liver disease studied, showed abnormality of 
RBC production. When markedly anaemic patients were studied high incidence of 
both megaloblastic and ringsideroblastic changes were seen. (Eichiner R and 
Hillmans) 
 
According to Cirera I, Panes J, Bordas J.M., LLach J, Busch J., Pique J.M., Teres J. in 
their study showed that anaemia increases gastric blood flow in cirrhotic and non 
cirrhotic patients. (Source: GI endoscopy 1995- Nov.). In anaemic patients the index 
of the Hb Conc. of the gastric mucosa assessed by reflectance spectrophotometry was 
significantly decreased in Cirrhotic and non cirrhotic, where as the index of the O2 
saturation was increased. In conclusion, chronic anaemia is associated with an 
enhanced gastric blood flow and gastric mucosal O2 index, despite a decrease in 
Gastric Hb Conc.  Cirrhotic anaemia further promotes further increment in its basal 
gastric hyperemia. 
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Authors- Siciliano M. Tomasello D. Miloni A. Ricerca B.M. Sterti S. Rossi L. found 
out reduced serum levels of immunoreactive erythropoietin (EPO) in patients with 
cirrhosis in chronic anaemia, (Source: Hepatology – 1995, Oct. 1132~5). Chronic 
anaemia is frequently seen inpatients with cirrhosis. To investigate the possible role of 
EPO in the pathogenesis of anaemia in cirrhosis, they measured the immunoreactive 
EPO levels and the respective Hb Conc. In 48 anaemic & non anaemic cirrhotic 
patients and in a control group of healthy subjects and in patients with iron deficiency 
anaemia.  A blunt EPO response to anaemia in cirrhosis. The study also showed that 
EPO levels for a given degree of anaemia were further reduced in patients with a more 
severe disease suggesting the close relationship between cirrhosis and the mechanism 
involved in the derangement of EPO feedback system. 
 
HEMOLYTIC SYNDROMES IN LIVER DISORDERS. 
Many of the features of hemolytic anaemia like raised bilirubin ConC., Reduced or 
absent haptoglobin and shortened RBC survival are found in uncomplicated liver 
disease.  One study demonstrated RBC life span to be reduced to about 50 % in 
patients with cirrhosis.  
 
 The Cause of hemolytic anaemia may be grouped broadly into extra corpuscular and 
intra corpuscular. There are two major extra corpuscular causes. They are 
Hypersplenism and lipid abnormalities. The latter induces alterations in the RBC 
membranes. The spleen plays a central role in conditioning the RBC, a process where 
by the spleen progressively erodes the membranes of RBC entrapped within its 
specialized circulation to cause spherocytes and hemolysis. 
 The finding in hyperlipemic variety of hemolytic anaemia in cirrhosis differs sharply. 
Episodes of hemolysis appear to be precipitated when alcoholics indulge in   heavy 
drinks; characteristically blood shows hypercholesterolemia with or without increased 
values of lipid. Hemolysis in this group probably relate to the presence of abnormal 
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serum lipids or abnormal distribution of serum lipids. Abnormality in serum lipids 
seems to alter the RBC membranes to make it more fragile. Subsequently, this fragility 
leads to hemolysis of RBC and leads to hemolytic anaemia. 
 
 Zieves syndrome or 
Hyperlipemic anaemia 
Hypersplenism with 
anaemia 
Clinically Mild Moderate to severe 
Fatty infiltrations Frequent Infrequent 
Hemoptysis Marked Variable 
Splenomegaly Absent Marked 
Lipids Increased Normal 
Fragility Increased Normal 
Bilirubin ratio Not decreased  Decreased 
Bone marrow 
hyperplasia 
Variable Variable 
Duration of illness Brief Prolonged 
Improvements Marked Slight or absent 
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ABNORMALITIES IN RED BLOOD CELL SHAPE. 
ABNORMALITY LIVER DISEASE 
Macrocytes Alcoholic cirrhosis 
Target cells Cirrhosis 
Spherocytes Zieve’s syndrome associated with 
alcoholic cirrhosis 
Echinocytes, Acanthocytes Severe form of  cirrhosis 
Stomatocytes, tear drop, poikilocytes Alcoholic cirrhosis 
 
Above mentioned table indicate various abnormal RBC shape. Macrocytosis is found 
in approximately two third of patients with chronic liver disease and upto ninety % of 
alcoholics. 
 
BINGAM in his classic papers described three types of Macrocytosis in liver disease. 
Thin Macrocytosis, target Macrocytosis and thick Macrocytosis.  Thin macrocytosis is 
common, characterized by increased RBC diameter with slight increase in MCV.  
Target macrocytosis is one where thin macrocytes have formed target cells.  Thick or 
true macrocytosis is associated with a marked increase in MCV which is less common 
in cirrhosis. 
 
The precise mechanism responsible for the macrocytosis of the liver disease is unclear 
but increase in RBC membrane cholesterol and phospholipids contents is likely to be 
important. Additional mechanisms for the macrocytosis would include the 
reticulocytosis associated with hemolysis or bleeding, and disturbances of Vit.B12 and 
folic acid metabolism. 
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BINGAM concluded from cross transfusion studies that there was an intrinsic 
abnormality in bone marrow erythropoiesis, and it is likely that alcoholics and patients 
with chronic liver disease do indeed have disturbed erythropoiesis which is 
macronormoblastic. 
 
In Routine blood films, Target cells are seen in most patients with significant liver 
disease as their RBC membrane contains more cholesterol or more cholesterol and 
phospholipids, than that of normal cells. The surface area expands without 
corresponding changes in volume and as a consequence the cell become “BOWEL or 
SAUCER” shaped. Although this shape is obvious in wet films and on scanning 
electron microscopy, drying prior to staining distorts the cell and in conventional 
blood films they appear “target cells”. As darker cells are also seen in familial LCAT 
deficiency, their presence in liver disease may result from low LCAT activity and 
transfer of lipid to RED cell s from cholesterol rich Lipoprotein particles. As volume 
should not be increased by expansion of the membranes, target cell formation is 
unlikely to be the reason for the macrocytosis often seen in liver disease. 
 
In conventional blood films RBC from patients with cirrhosis often appear normal in 
shape except for the presence of target cells. However in wet films or on scanning 
electron microscopy, many patients have speculated RBC or echinocytes in the blood. 
Sometimes when the numbers are very large and cells have many spicules, spiky 
RBCs are seen in conventional blood films. 
 
 The presence of echinocytes appears to be related to changes in HDL, Purified HDL 
from blood containing echinocytes transforms normal RBCs. The cells rapidly revert 
to normal incubation with albumin or normal HDL.  The HDL induced echinocytosis 
is not accompanied by enrichment for echinocytogenesis in liver diseases; although, 
one would expect the cells in liver disease do have a high cholesterol phospholipids 
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ratio of abnormal HDL by the RBC surface. The pathophysiological significance of 
shape changes in RBCs is unknown, and there appears to be no clear relationship 
between the echinocytes and the Hb level. 
 
 RBC of bizarre shape are seen occasionally in Blood of cirrhotic in association with 
the hemolytic anaemia (SPUR CELL ANAEMIA). The term spur cell anaemia should 
only be applied when acanthocytes are present.  Their shape is quite different from that 
of echinocytes but the distinction is not always consistently made. The cirrhosis is 
usually but not invariably, alcoholic in origin. The liver disease tends to be quite 
severe with jaundice, ascites, encephalopathy and, or GI Haemorrhage preceding or 
following the development of hemolysis; although the patients may survive many 
months with acanthocytosis, the prognosis of the underlying  liver disease is poor. 
Only a small proportion of the RBC in these patients is acanthocytes. Most of the 
remaining cells are typical echinocytes.  The echinocytes, but not the acanthocytes 
have been produced invitro incubating normal RBCs in sera of patients with spur cell 
anaemia, it was suggested that the shape change is caused by marked elevation of the 
membrane cholesterol Phospholipids ratio.   
 
WBC CHANGES IN LIVER DISEASES. 
 WBC abnormalities in liver disease may be due to underlying disease or its therapy and range 
from neutrophilia to neutropenia and lymphopenia.  Leucocytosis occurs in response to 
infections, Hemorrhage, hemolysis and malignancy.  A mild leucopenia is frequently 
encountered in patients with chronic liver disease and reflects either hypersplenism or a toxic 
effect on bone marrow. In addition to causing leucopenia, alcohol has well recognized toxic 
effects on neutrophills and also on lymphocytic functions which cause defect in both cellular 
and humoral immunity. 
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Increased susceptibility to infection is well recognized in chronic liver disease and this is 
likely to be due to combination of mechanisms. Specific areas of Haemotological interests are 
disturbances of neutrophill function, lymphocytes function and complement activation. 
Neutrophill Chemotaxis has been found to be depressed in the presence of patients serum, 
although the chemotactic response of the cells themselves is normal in the presence of normal 
serum. This effect is due to low level of alternate pathway complement systems and 
reductions in these components have been reported in chronic liver disease. The high levels of 
IgA which are frequently found in patients with alcoholic cirrhosis and cryptogenic cirrhosis 
may form aggregates or complexes and thus inhibit chemotaxis. 
 
LIVER DISEASE AND PLATELETS. 
Defects of platelet functions and number are well documented in patients with chronic 
liver diseases and contributed significantly to their hemostatic abnormalities. A 
number of studies examined platelet kinetics in patients with chronic liver disease. 
The studies have demonstrated a diverse etiology for thrombocytopenia of liver 
disease. They are  
1.  Shortened platelets mean life time. 
2. Pooling of platelet within enlarged spleen. 
3. Inability of the bone marrow to compensate adequately for thrombocytopenia. 
 
There is no clear relationship between abnormalities of platelets kinetics and the 
severity of liver disease and very low counts are often seen with portal hypertension 
and spleenomegaly, in patients who have relatively normal LFT. 
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It has recently been suggested that impaired synthesis of thrombopoietic factor 
normally produced by the liver may contribute to the thrombocytopenia of liver 
disease. There is evidence that platelets responsiveness is impaired in chronic liver 
disease and their aggregation may be impaired by both intrinsic platelet defect and by 
circulating inhibitors of aggregation. The causes of the functional abnormalities are 
probably similarly to the underlying causes of the  thrombocytopenia and included  
platelet activation, perhaps by adhesion to incompletely endothelialized sinusoids, 
enzymatic alterations of the platelet membrane and metabolic factor associated with 
the  cirrhotic process or its causes. 
 
Normal platelets enriched with cholesterol show increased aggregability by ADP and 
adrenaline. Platelets in liver disease tend to be cholesterol   rich but their aggregability 
is diminished probably because the arachidonic acid content of the platelet 
phospholipids is reduced, this may diminished production of proaggregating TxA2. 
 
A raised level of platelets associated Ig is found in a proportion of patients with 
chronic liver disease suggesting that antibody mediated platelet destruction may 
contribute it the shortened platelet survival in some patients. 
THE EFFECT OF CIRRHOSIS ON HAEMOSTASIS. 
Liver produces various proteins which help in the maintenance of normal haemostasis. 
It produces procoagulants, anti coagulants, profibrinolytics and anti fibrinolytics. 
 
 Vitamin K dependant coagulation proteins are synthesized in the liver in a precursor 
form. These non functional proteins are called “Protein induced in Vit. K absence” 
(PIVKA).  The conversion of PIVKA factor to the biologically active form involves 
carboxylation of the alpha carbon of specific glutamic acid residue in the N-terminal 
regions. 
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 Antithrombin III is a glycoprotein which is synthesized by both hepatocyte and 
endothelial cells.  It behaves as an anti coagulants as evidenced by the observation that 
a relatively small reduction of serum antithrombin III is associated with an increased 
risk of venous thrombosis.  The low level of serum antithrombin II in liver cirrhosis 
are due to impaired synthesis rather than increased metabolism. 
 
An increased amount of fibrinogen is produce in cirrhosis. The fibrinogen that is 
produced in liver disease is often abnormal and shows defective polymerization. An 
excess amount of low molecular weight fibrinogen is produced. Acquired 
dysfibrinogenaemia occurs in any patients with chronic liver disease and seems to 
reflect the severity of the impairment of the liver function.  
 
Accelerated fibrinolysis is a recognized complication of cirrhosis. In addition to 
synthesizing plasminogen, the liver also synthesizes the main plasmin inhibitor, alpha 
2 plasmin inhibitor. There is also impaired clearance of plasminogen activators. Thus 
the mechanism of increased fibrinolysis is multifactorial and due to increased levels of  
circulating  plasminogen activators, caused by decreased clearance  and reduced  
inhibition of plasmin as a result of diminished synthesis of plasmin inhibitors.  
 
The effects of chronic liver disease on Hemostasis are illustrated in the table below. 
 THE EFFECT OF LIVER DISEASE ON HAEMOSTASIS. 
I. Decreased synthesis of proteins. 
Coagulation : Factor XII, XI, IX, VII, II, Fibrinogen, prekallikrein, 
Kininogen. 
Anticoagulant : Protein C and S, Antithrombin III. 
Profibrinolytic : Plasminogen. 
Antifibrinolytic : 2-Antiplasmin, C-1 inhibitor, 2-Macroglobulin, 
histidine rich glycoprotein. 
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II.  Synthesis of abnormal proteins. 
Vitamin K dependant factors. 
Factor VIII & Von willibrand Factor. 
Fibrinogen. 
III.   Decreased clearance functions. 
Activated Coagulation factors. 
Plasminogen activators. 
Thrombin Anti thrombin III complexes. 
IV. Abnormalities of platelets.   
DIC 
 
DESIGN OF THE STUDY (MATERIALS AND METHODS) 
This study was conducted in Government Stanley hospital, Chennai – 3, Between 
Sept-2005 to Aug-2006. Fifty patients suffering from cirrhosis were selected in 
random for the study.  42 of them were males & 8 were females. 
 
Blood samples obtained from the patients were personally handed over to clinical 
pathological dept. The age group of the patients was from 20 to 65 years. 
 
Age in years No. of patients Percentage 
20 ~ 35  8 16 
36 ~ 50 32 64 
51~65 10 20 
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The majority of the patients were daily wage coolies, coming from lower socio-
economic group. Their diet is particularly poor in protein. Past history of Jaundice was 
obtained in 16 patients. History f alcoholism was obtained in 36 patients. In the 
majority of patients Oesophageal varices seen in upper GI endoscopy were taken as 
indirect evidence while tissue proof obtained by performing the liver biopsy was 
considered to be direct evidence of cirrhosis. 
 
USG abdomen was routinely performed in all the patients. In these patients in whom 
liver biopsy was not performed due to contraindication or in whom the procedure was 
not successful, the coarse heterogenous echotexture of liver found in these patients 
was considered to be the direct evidence for the cirrhosis. Bone marrow study was 
carried out in forty patients. 
 
The following Haematological studies were carried out to assess red blood cell 
abnormality. 
1. RBC count. 
2. Heamoglobin Estimation. 
3. PCV 
4. MCV 
5. MCHC 
6. Peripheral Smear 
7. Reticulocyte count 
 
To assess white blood cell abnormality 
1. Total WBC count 
2. DC 
 
To assess Haemostasis 
1. Platelet count 
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2. Bleeding time / Clotting time 
3. Prothrombin time 
 
The proforma used for clinical, biochemical and Haematological evaluation is given 
below. 
 
HEAMATOLOGICAL ABNORMALITIES IN CIRRHOSIS OF LIVER 
 
 
28
PROFORMA 
 
Study in various haematological abnormalities in cirrhosis of liver 
Name: 
Age: 
Sex: 
IP No: 
 
Presenting complaints: 
 
History of Present illness 
Nausea / Anorexia   Difficulty in breathing 
Vomiting    Loss of weight 
Haematemesis   Haematochezia 
Malena    Constipation 
Abdominal Distention  Diarrhoea 
Swelling of legs   Jaundice 
Oliguria    Mental Confusion 
Abdominal Pain   Other Symptoms 
Loss of consciousness 
Chest pain 
 
History of Past illness 
Jaundice    Surgery 
Tuberculosis    Needle pricks 
Blood transfusion   Malignancy 
Diabetes Mellitus   GI Bleed 
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Personal History 
Alcohol 
Smoking 
Others 
 
Family History 
Chronic Liver Disease 
Diabetes Mellitus 
Others 
 
Clinical Examination 
General Examination 
Built    Nourishment 
Consciousness  Clubbing 
Anaemia   Cyanosis 
Jaundice   Lymphadenopathy 
Pedal Edema 
 
Stigmata of chronic liver disease 
Face    Hands 
Telangiectasia  White nails 
Xanthelasma   Dupuytren’s contracture 
Paper monkey skin  palmar erythema 
KF Ring 
Cushingoid Facies 
Parotid Enlargement 
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Skin    Endocrine 
Spider naevi   Gynaecomastia 
Scanty body hair  Atrophic testes 
Slate grey pigmentation 
Scratch Marks 
 
Vital Signs 
Pulse 
BP 
Respiratory Rate 
Temperature 
 
Systemic Examination 
CVS : 
RS : 
CNS : 
ABDOMEN: Ascites 
  Splenomegaly 
  Dilated Veins over abdomen 
  Hernia 
  Hydrocele 
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Investigation 
Blood 
TC     MCV 
DC     MCHC 
RBC     Reticulocyte count 
HB%     Platelet count 
PCV     Bleeding time 
Urea     Clotting time 
Sugar     Prothrombin time 
     Peripheral Smear 
 
Urine 
Albumin 
Sugar 
Deposits 
Bile Salts 
Bile Pigments 
Urobilinogen 
Serum 
Creatinine 
Electrolytes 
Bilirubin 
SGOT 
SGPT 
SAP 
Albumin 
Globulin 
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Ascitic fluid Analysis 
Total Protein 
Cellular Analysis 
Bone Marrow studies 
Viral Markers 
HBS Ag, Anti HCV Antibodies 
 
X-ray Chest 
ECG 
Ultra sound abdomen 
UGI Endoscopy 
Liver Biopsy 
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Range of RBC count in our Study
2.5-3 
mil/cum
m 22%
3-3.5 
mil/cum
m 38%
3.5-4 
mil/cum
m 28%
4-5.4 
mil/cum
m 12%
2.5-3 mil/cumm 3-3.5 mil/cumm
3.5-4 mil/cumm 4-5.4 mil/cumm
 
 
 
Hb Values
7-9 gm
22%
9-11 gm
52%
11-13 gm
14%
>13 gm
12%
7-9 gm 9-11 gm 11-13 gm >13 gm
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Leucocyte Count
3000-6000
22%
6001-9000
28%
9001-12000
32%
>12000
18%
3000-6000 6001-9000 9001-12000 >12000
 
 
Platelet Count
50000-
100000, 
8%
100001-
150000, 
26%
150001-
200000, 
40%
>200000
, 26%
50000-100000 100001-150000
150001-200000 >200000
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Relationship of Prothrombin Concentration in the blood to the Prothrombin Time
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DATA ANALYSIS 
Our cases were analysed for the presence or absence of anaemia and the characteristic 
of the anaemia when present. 41 Patients (82%) had anaemia. Microcytic anaemia was 
demonstrable in 6 patients, normocytic anaemia was demonstrable in 25 patients and 
macrocytic anaemia was demonstrable in 10 patients, one patient showed dimorphic 
anaemia. Macrocytosis without anaemia was present in 3 cases/ Microcytic anaemia 
patients peripheral smear showed anisocytosis and poikilocytosis. Target cells and 
acanthocytes were seen in a single case. The patient with macrocytic anaemia had 
mean corpuscular volume more than 94 fl. There was no correlation between the 
severity of anaemia and the type of cirrhosis. 
 
Table-1 
Total RBC count Cases Percentage 
2.5 – 3 Million/mm3 11 22 
3.0 – 3.5 Million/mm3 19 38 
3.5 – 4.0 Million/mm3 14 28 
4.0 – 5.4 Million/mm3 6 12 
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Table – II 
Hemoglobin Values 
Hemoglobin % Cases Percentage 
7 – 9 11  22 
9 – 11 26 52 
11 – 13 7 14 
> 13 6 12 
 
Table III 
Type of RBC Alcoholic Cirrhosis Other Cases 
Normocytic 10 19 
Microcytic 6 5 
Macrocytic 10 - 
 
Table IV 
Type of RBC Anaemia  Normal HB% 
Normocytic 25 6 
Microcytic 6 - 
Macrocytic 10 3 
Total 41 9 
 
 
HEAMATOLOGICAL ABNORMALITIES IN CIRRHOSIS OF LIVER 
 
 
38
LEUCOCYTES 
The total WBC count in 4 patients is less than 4000 cells / cumm and normal counts 
(4000 – 11000 cells / cumm) were present in 32 patients. Leucocytosis was observed 
in 14 patients. There was no relationship between the total Leucocyte counts and the 
presence of splenomegaly or bleeding time. Since leucopenia and Leucocytosis 
occurred with greater frequency among patients with infection like spontaneous 
bacterial peritonitis and urinary tract infection. Lymphocytosis was observed in 4 
patients where as lymphopenia was observed in 9 patients. Neutrophilia was observed 
in 8 patients. 
 
Table V 
Total count (Cells/cumm) Number of patients Percentage 
3000 - 6000 11 22 
6001 - 9000 14 28 
9001 - 12000 16 32 
> 12000 9 18 
 
PLATELET 
Thrombocytopenia is the term used when the platelet count is less than 1,50,000 
cells/cumm. In our study thrombocytopenia was observed in 17 patients. We 
encountered the following values given in the table. 
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Table VI 
Platelet Count (Cells/cumm) Number of patients Percentage 
50000 – 1,00,000 4 8 
1,00.000 – 1,50,000 13 26 
1,50,000 – 2,00,000 20 40 
> 2,00,000 13 26 
 
The prothrombin time was normal in 16 patients and it is prolonged in 34 patients, 
bleeding time was prolonged in 4 patients who showed very low platelet count. Liver 
biopsy was not done for those patients because of bleeding risk. Clotting time was 
normal in most of the patients. Bone marrow was normocellular in 32 patients and in 
14 cases it was hyperplasic. There was no hypoplastic change. There were no 
megaloblastic changes. 
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DISCUSSION 
This study was conducted mainly to assess the haematological profile in cirrhotic 
patients. Cirrhosis of liver in various parts of the world presents some what differing 
clinical picture. Davidson, Sherlock, Turner contrast the behaviour of Cirrhosis in 
Europe and America where alcoholism is the common factor in the aetiology. Age 
incidence reported is usually above 35 years. Males preponderate. History of previous 
hepatitis is rare while ascites and jaundice is the common mode of presentation. 
Parotid enlargement, gynaecomastia, anaemia are common. The liver is often large. 
Spleen is palpable in 25% of cases. Ascites is extremely common. Serum albumin is 
low. In contrast non-alcoholic Cirrhosis which is relatively more common in England 
is reported to show female predominance. There is no particular age incidence. History 
of previous hepatitis is present in 30% of cases. Portal Hypertension is common. 
Gynaecomastia is rare, while liver is small, spleen is palpable as a rule. Coexistent 
peptic ulcer has been reported. Serum albumin is low in decompensated liver. 
 
In Our series of study, most of the cases were between 20 – 65 years. Sex incidence 
was male and female 5:1 ratio, in our series. In our study 2 / 3 of patients belonged to 
urban and semi-urban areas, commonest group affected belonged to lower socio 
economic group. Their average monthly income was Rs.700 – 1500/-. Definite history 
of alcoholism for prolonged period was observed in 75% of the patients in our study. 
 
Anaemia is a very common problem in patients with Cirrhosis of liver. The morbidity 
and mortality of the patients suffering from Cirrhosis of liver is much influenced by 
presence of associated anaemia. Correction of some reversible factors like anaemia 
may improve the quality of life and prolong their life span. Anaemia incidence 
reported by various authors ranges from 42 – 92% (Jarrold and Wilters) (21) 
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Different types of anaemia have been observed by various authors 
Type of Anaemia  No. of 
cases 
Incidence of 
Anaemia 
 
% 
Normo 
cytic 
% 
Macro 
cytic 
% 
Micro 
cytic 
% 
Rosen Beng (1936) 62 42 6.4 89.7 3.9 
Bianoco Jolliffec 
(1936) 
30  26.4 52.8 19.8 
Wintrobe (1936) 48 84 30.0 40.9 7.12 
Malhotra (1951) 32 90.6 84.35 6.25 0.0 
Sen Gupta (1958) 45 76 40 31.0 5.0 
Bhatia (1961) 77 83 59.7 18.6 5.0 
Mishra et al (1982) 674 91.6 79.8 5.64 5.8 
Present Series 50 82 50 20 12 
 
In our study the incident of anaemia was 82%. Wintrobe and Schumaker concluded 
that macrocytic anaemia resulted from defective storage and metabolism of 
haemopoietic principles as a consequence of inability of the damaged liver to perform 
normal function. (Western authors who have shown macrocytic anaemia 89.7%), 
normocytic anaemia (6.4%) microcytic anaemia 3.9%, with an incidence of 92% 
anaemia. The North Indian authors study showed Normocytic anaemia 79.8%, 
macrocytic anaemia 5.6%, and microcytic anaemia 5.8% with an incidence of 91.6% 
anaemia. In our study, Normocytic anaemia 50%, microcytic anaemia 12%, 
macrocytic anaemia 20% with an incidence of 82% of anaemia. Saragea and wallier 
came to the conclusion that GI Bleeding was the major cause of anaemia in cirrhotic. 
HEAMATOLOGICAL ABNORMALITIES IN CIRRHOSIS OF LIVER 
 
 
42
Capps, Weinstein and Elinger showed that majority of cases of anaemia are due to 
hypersplenism and haemolysis. Khondaky and Rosseclin Ghata observed that Folic 
Acid and B12 deficiencies are cause for anaemia. Deller et al showed that the mean 
haemoglobin value in alcoholic cirrhosis is much lower than that of post necrotic 
cirrhosis. About 1-2 gm differences was observed. 
 
There was no correlation between target cells and type of cirrhosis. Neither the type of 
the severity of liver disease had any influence on the frequency of macrocytosis. Mean 
corpuscular haemoglobin concentration was subnormal. Anisocytosis and 
poikilocytosis did not appear to be related to either the severity or the type of anaemia. 
Bone marrow in cirrhosis with Anaemia (Misra et al) showed that 52 cases were 
normoblastic in reaction 6 cases macronormoblastic 2 cases megaloblastic. Kimber et 
al in his studies of 93 cases, reported that Bone marrow was hyperplastic in 70 cases, 
Hypoplastic in 3 cases and normal in 20 cases. 
 
The bone marrow was normal in 35 cases, hypoplastic in 5 cases, and hyperplastic in 6 
cases. The marrow reaction was much influenced by malnutrition and blood loss. No 
correlation was found between marrow cellularity and anaemia either to the type of 
liver disease or to its severity. The major cause of anaemia was malnutrition acute and 
chronic blood loss, associated malarial infection, peptic ulcer and worm infestation. 
The existing symptoms were worsened by presence of anaemia. The morbidity was 
found to be directly proportional to severity of anaemia. The severity and type of 
anaemia was not related to type of cirrhosis. 
 
Thrombocytopenia was also observed in our study, 34% of the patients platelet count 
was less than 1,50,000. Clinically except for two patients who had purpuric spots who 
had platelet count below 1,00,000 none of the other patients had any referable clinical 
signs related to thrombocytopenia. The possible mechanism of platelet deficiency in 
these patients probably could be due to liver cell failure and vitamin K deficiency. 
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Whether these patients needed any life long vitamin K supplement was a debatable 
one because of the paucity of clinical signs related to thrombocytopenia. Still these 
patients have to be carefully followed up for periodical platelets count, to prevent any 
bleeding complication. There was no relationship between the total WBC count and 
the presence of splenomegaly or bleeding time. Since leucopenia and leucocytosis and 
normal counts were present. However, leucocytosis occurred with greater frequency 
among patients with infection like spontaneous bacterial peritonitis and UTI. 
Lymphocytosis was observed in four patients where as lymphopenia was observed in 
nine patients. Neutrophilia was observed in eight patients. 
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SUMMARY AND CONCLUSION 
 
This limited study aimed at the evaluation of haematological profile in liver cirrhosis 
patients. As expected most of the patients have some form of disturbance in the 
haematological profile. Majority of the patients suffered from anaemia in one form or 
other. 
 
Next in the order is referable to platelet abnormalities. Thirdly small proportion of 
patients found to be suffering from leucocytes disturbances. 
 
Since anaemia is found to be the major haematological abnormality in our study we 
aimed at correcting this problem first by giving either packed cell volume or whole 
blood transfusion as the case may be. This definitely as reduce the immediate 
mortality. 
 
Hence, we suggest that all cirrhotic patients should be carefully monitored regarding 
the haematological profile and correcting these abnormalities would certainly prevent 
death due to anaemia, inter current infections, sepsis and hypovolemic shock due to 
haemorrhage. 
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MASTER CHART 
differential 
count 
Sl.No Name RBC 
count 
Hb 
gm/dl. PCV MCV MCHC 
Type of 
anaemia 
Total 
WBC 
count 
per 
cu.mm 
P L E M 
Comments Platelet 
count 
prothrombin 
time in sec 
 Bone 
marrow 
study 
1 Nagaraj 3.42 10 32 93.5 31.2 normocytic 
normochromic 9800 55 43 2 0 normal 160000 25 normal 
2 Seenu 3.3 9.2 24 71 38 microcytic, 
normochromic 9900 69 23 8 0 normal 190000 27 hyperblastic 
3 Viji 3.6 8.2 24 80.5 35.1 normocytic 
normochromic 8600 84 10 6 0 lymphopenia 130300 22 normal 
4 Mani 4.2 13.8 40 90.5 30.4 normocytic 
normochromic 8200 58 36 6 0 normal 220000 20 normal 
5 chandrasekar 2.9 9.2 27 93 34 normocytic 
normochromic 5900 72 24 4 0 normal 440000 24 hyperblastic 
6 Velu 3.2 10 33 103.1 30.3 macrocytic, 
normochromic 10400 82 12 6 0 lymphopenia 155000 25 normal 
7 Adam 3.4 10.8 30 88.2 36 normocytic 
normochromic 9600 78 15 7 0 lymphopenia 63000 38 normal 
8 Pandian 3.64 10.5 35 96.9 30 macrocytic, 
normochromic 3800 78 13 9 0 leucopenia 120000 28 normal 
9 Ramesh 3.42 10.1 30 96.9 33.3 normocytic 
normochromic 13200 74 14 11 0 leucocytosis 170000 24 normal 
10 Chinnappa 4.1 13.2 39 90.5 33.8 normocytic 
normochromic 9900 66 32 2 0 normal 220000 22 normal 
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MASTER CHART 
differential 
count 
Sl.No Name RBC 
count 
Hb 
gm/dl. PCV MCV MCHC 
Type of 
anaemia 
Total 
WBC 
count 
per 
cu.mm 
P L E M 
Comments Platelet 
count 
prothrombin 
time in sec 
 Bone 
marrow 
study 
11 Gopinath 2.6 7 19 73 36.8 microcytic, 
normochromic 13400 80 18 2 0 leucocytosis 140000 28 hyperblastic 
12 Baskar 3.8 12 34 89.4 32.2 normocytic 
normochromic 8900 70 25 5 0 normal 160000 22 normal 
13 Bhoominath 3.4 10.4 28 82 37 normocytic 
normochromic 12200 73 13 14 0 leucocytosis 130000 30 normal 
14 Ramnath 3.81 12.8 39 102.6 32.3 macrocytic, 
normochromic 9100 72 23 5 0 normal 180000 24 normal 
15 Pandian 3.88 13 39 101.50 33.3 macrocytic, 
normochromic 3900 54 42 4 0 leucopenia 120000 32 hypoblastic 
16 Palraj 2.88 9.5 28 97.2 33.9 macrocytic, 
normochromic 11200 74 24 2 0 leucocytosis 190000 29 normal 
17 Veeraiya 3.4 8.8 25 73.5 35.4 microcytic, 
normochromic 4700 62 36 2 0 normal 160000 30 - 
18 Seenu 3.9 13.20 40 102 33 macrocytic, 
normochromic 7600 58 37 5 0 normal 250000 22 hypoblastic 
19 Thangavel 2.9 9 26 89.6 35.6 normocytic 
normochromic 13200 70 26 4 0 leucocytosis 80000 40 - 
20 Yuvaraj 3.8 8 27 71 29.6 microcytic, 
normochromic 5500 68 30 2 0 normal 160000 27 normal 
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MASTER CHART 
differential 
count 
Sl.No Name RBC 
count 
Hb 
gm/dl. PCV MCV MCHC 
Type of 
anaemia 
Total 
WBC 
count per 
cu.mm P L E M 
Comments Platelet 
count 
prothrombin 
time in sec 
 Bone 
marrow 
study 
21 Raghavan 3.14 9.5 27 85.9 35 normocytic 
normochromic 8200 60 37 3 0 normal 210000 29 normal 
22 Arjunan 3.07 9.3 28 86.2 33.2 dimorphic 10400 80 14 6 0 lymphopenia 220000 23 normal 
23 Abdul 2.9 8.8 25 86.2 35.2 normocytic 
normochromic 7500 38 54 8 0 lymphopenia 140000 26 - 
24 Kuppan 3.65 12 35 95.8 34.2 macrocytic, 
normochromic 5100 66 26 8 0 normal 120000 29 normal 
25 Pichaiya 3.52 11 33 93 33.3 normocytic 
normochromic 12800 70 24 6 0 leucocytosis 190000 26 normal 
26 Chinnaiyan 4.1 13.5 39 95 34.6 macrocytic, 
normochromic 10800 63 32 5 0 normal 202000 19 normal 
27 Govindhan 3.15 10.2 29 92 35.1 normocytic 
normochromic 13400 80 17 3 0 leucocytosis 200000 20 - 
28 Kannan 3.6 10.8 32 88.8 33.75 normocytic 
normochromic 8600 70 24 6 0 normal 150000 26 normal 
29 Subbaiyah 2.56 8.2 23 89.8 35.6 normocytic 
normochromic 9800 68 24 8 0 normal 160000 27 normal 
30 Saleema 3.2 9.2 30 88.2 36.6 normocytic 
normochromic 12900 74 22 4 0 leucocytosis 180000 27 normal 
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MASTER CHART 
differential 
count 
Sl.No Name RBC 
count 
Hb 
gm/dl. PCV MCV MCHC 
Type of 
anaemia 
Total 
WBC 
count 
per 
cu.mm P L E M 
Comments Platelet 
count 
prothrombin 
time in sec 
 Bone 
marrow 
study 
31 Pattu 2.9 7.5 21 72.4 35.1 microcytic, 
normochromic 3900 59 38 2 1 leucocytosis 110000 30 hyperblastic 
32 Venkat 3.6 12 33 91.6 36 normocytic 
normochromic 7100 66 28 6 0 normal 210000 19 normal 
33 Vijaya 3.24 9.6 29 80.2 33.1 normocytic 
normochromic 4600 49 47 4 0 lymphocytosis 150000 23 normal 
34 Padma 3.08 9.4 28 90.9 33.5 normocytic 
normochromic 11200 64 34 2 0 normal 140000 30 normal 
35 Veeran 2.56 8.2 23 89.8 35.6 normocytic 
normochromic 9800 68 24 8 0 normal 160000 27 normal 
36 Thirumalai 3.88 13 39 100.5 33.3 macrocytic, 
normochromic 3900 54 42 4 0 leucopenia 120000 32 hypoblastic 
37 Velan 3.07 9.3 28 86.2 33.2 dimorphic 10400 80 14 6 0 lymphopenia 220000 23 normal 
38 Kadhir 2.9 8.8 25 86.2 35.2 normocytic 
normochromic 7500 38 54 8 0 lymphopenia 140000 26 - 
39 Kumar 3.81 12.8 39 102.6 32.3 macrocytic, 
normochromic 9100 72 23 5 0 normal 180000 24 normal 
40 Ananth 3.2 10 33 103.6 30.3 macrocytic, 
normochromic 10400 82 12 6 0 lymphopenia 155000 25 normal 
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MASTER CHART 
differential 
count 
Sl.No Name RBC 
count 
Hb 
gm/dl. PCV MCV MCHC 
Type of 
anaemia 
Total 
WBC 
count 
per 
cu.mm P L E M 
Comments Platelet 
count 
prothrombin 
time in sec 
 Bone 
marrow 
study 
41 Senthil 3.64 10.5 35 96.9 30 macrocytic, 
normochromic 3800 78 13 9 0 leucopenia 120000 28 normal 
42 Umir 3.42 10 32 93.5 31.2 normocytic 
normochromic 9800 55 43 2 0 normal 160000 25 normal 
43 Selvi 3.2 9.2 30 88.2 30.6 normocytic 
normochromic 12900 24 22 4 0 leucocytosis 180000 27 normal 
44 Balu 3.4 8.8 25 73.5 35.2 microcytic, 
normochromic 4700 62 36 2 0 normal 160000 30 - 
45 Palanichamy 4.1 13.5 39 95 30.4 macrocytic, 
normochromic 10800 63 32 5 0 normal 202000 19 hypoblastic 
46 Sellaia 3.65 12 35 95.8 34.2 macrocytic, 
normochromic 5100 66 26 8 0 normal 120000 28 hypoblastic 
47 Murugan 3.6 12 33 91.6 36 normocytic 
normochromic 12100 66 28 6 0 normal 210000 19 normal 
48 Arul 3.3 9.2 24 71 32 microcytic, 
normochromic 9900 69 23 8 0 normal 109000 27 hyperblastic 
49 Kapali 2.9 9.2 27 93 34 normocytic 
normochromic 5900 72 24 4 0 normal 440000 24 hyperblastic 
50 Kesavan 4.1 13.5 39 95 34.6 macrocytic, 
normochromic 10800 63 32 5 0 normal 202000 19 - 
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